TCF Awards to donate percentage of profits to help young healthcare talent
AMV BBDO, DROGA5 & CO. JOIN THE ONLY HEALTHCARE AWARD SHOW ON EARTH TO DONATE A PERCENTAGE OF PROFITS TO HELP YOUNG TALENT.
Why are healthcare award shows always run by people who have never worked in an ad agency?
Or ever won a creative award? And when they claim to have an educational element, why do they end up charging for that bit too?
Rather than complain about all that’s wrong with current healthcare award shows, we thought we’d do something about it:
1. A percentage of profits will be re-invested to help the next generation of talent break into our industry
2. The winners of the show decide where that money goes
3. No hidden rip-off fees or elitist categories
4. The only award show in the world to be run by creative’s
5. The only award show with judges from the best of consumer and healthcare:
Peter Souter, Chairman/CCO, TBWA London
Daryl Corps, CD, Droga5, Sydney
Simon Rice, CD, AMV BBDO
Andrew Spurgeon, CD, Langland
Jolyon Finch, CD, Publicis London
Alex Von Plato, Global CCO, Digitas Health
Phil Cockrell, CD, DLKW/Lowe
Denis Mamo, CD, UrsaClemenger, Melbourne
Kathy Delaney, Global CCO, Saatchi and Saatchi Wellness
Sean Riley, ECD, McCann Health Singapore and South East Asia
ENTRIES NOW OPEN:
Early Bird Deadline: 28 February 2014
Final Deadline For All Entries: 28 March 2014
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”